antagonists & inhibitors

Known as: inhibitor/antagonist 
Used with chemicals, drugs, and endogenous substances to indicate substances or agents which counteract their biological effects by any mechanism.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2013
01219972013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
One out of every three people will suffer either a stroke or develop Alzheimer’s disease (AD). In a world with continuous… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Proangiogenic gene therapy, with viral and non-viral vectors, has been shown to be highly efficient in several animal models… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2006
Review
2006
The United States FDA approved 85 New Molecular Entities (NMEs) during the period from January 2001 to November 2004 of which 60… (More)
Is this relevant?
2006
2006
Gene therapy has become a promising alternative treatment form for cancer. Among the broad range of different genetic means to… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2003
2003
OBJECTIVE Angiotensin (Ang) is broken down enzymatically to several different metabolites which, in addition to Ang II, may have… (More)
Is this relevant?
1997
1997
A leukotriene biosynthesis inhibitor (MK886), a platelet-activating factor (PAF)-receptor antagonist (WEB 2086), a recombinant… (More)
Is this relevant?